Status:
UNKNOWN
SMS Reminders and Treatment Compliance and Efficacy in Patients With FGIDs
Lead Sponsor:
RenJi Hospital
Conditions:
Functional Gastrointestinal Disorders
Patient Compliance
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The effect of SMS follow-up on drug compliance and efficacy in patients with FGIDs has not been reported in the literature. We, therefore, conducted a prospective randomized controlled trial to invest...
Detailed Description
The irritable bowel syndrome (IBS) and other functional gastrointestinal disorders (FGIDs) are common and pose significant burdens to patients. Although regular medications have substantial benefits f...
Eligibility Criteria
Inclusion
- Patients with newly diagnosed FGIDs according to Rome-IV
- Aged 18-70 years
- With no obvious organic abnormalities
Exclusion
- With organic gastrointestinal diseases
- With psychiatric diseases or are taking psychotropic agents
- With severe cardiopulmonary or other organ diseases
- Pregnant women
Key Trial Info
Start Date :
April 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2021
Estimated Enrollment :
176 Patients enrolled
Trial Details
Trial ID
NCT04052750
Start Date
April 30 2019
End Date
April 30 2021
Last Update
August 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
RenJiH
Shanghai, China